Steroid-refractory Acute Graft Versus Host Disease

Explore clinical trials studying Steroid-refractory Acute Graft Versus Host Disease. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Steroid-refractory Acute Graft Versus Host Disease trial results

Recruiting

Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease

NCT06462469

Conditions: Steroid-refractory Acute Graft Versus Host Disease
Locations: Novartis Investigative Site Guangzhou, Guangdong, China

Novartis Investigative Site Guangzhou, Guangdong, China

Novartis Investigative Site Zhengzhou, Henan, China

Novartis Investigative Site Wuhan, Hubei, China

View all 17 locations

View Trial Details